
Merck to buy Verona and its lung drug in $10B deal
Merck & Co. has agreed to pay $10 billion to buy London-based Verona Pharma, scooping up a potential multibillion-dollar new drug to treat chronic obstructive pulmonary disease in a deal announced Wednesday. The Food and Drug Administration approved …